In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

The Two Speeds of European Healthcare Finland is demonstrating a different approach to modern healthcare—one that prioritizes ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...

BeyondTrust has released security updates to fix a high-severity flaw in its Remote Support (RS) and Privileged Remote Access (PRA) solutions that can let unauthenticated attackers gain remote ...

With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of insurance status, under Zepbound Self Pay ...

Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions Jun. 16, 2025 6:45 AM ET Eli Lilly and Company (LLY) ...

INDIANAPOLIS, June 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)-12.5 mg and 15 mg-will soon be available in ...

Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss ...

You may be able to get a Mounjaro prescription online. We review the telehealth services that provide this FDA-approved medication.

Eli Lilly has decided to wait for the readout of the second of its two phase 3 trials for tirzepatide in obesity, rather than filing on the strength of its first, positive study. When Lilly ...

Treatment with tirzepatide reduced the risk of heart failure outcomes – specifically a heart failure urgent visit or hospitalisation, oral diuretic intensification, or cardiovascular death ...